OECD Home › Science and technology › Publications & Documents › Reports
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
This study shows how knowledge-intensive services activities (KISAs) contribute to the acquisition and growth capabilities of firms and public sector organisations.
English, , 371kb
This paper presents a revision of the 2002 OECD model survey on ICT use by households and individuals.
English, , 426kb
This paper presents a revised OECD model survey on information and communication technology (ICT) use by businesses.
English, , 442kb
Trust among the users of ICT networks is an increasing priority for business, industry and governments. This report reviews data available from official, semi-official and private sources which can assist in informing developments and progress in this area.
With case studies on Austria, Belgium (Flanders), Finland, Greece, Ireland, the Netherlands, Norway and Sweden, this book illustrates mechanisms and practices for better governance co-ordination and integration across policy areas.
OECD economic globalisation indicators help identify the economic activities of member countries under foreign control, and more particularly the contribution of multinational enterprises to growth, employment, productivity, labour compensation, R&D, technology diffusion and int trade.
This book presents case studies on innovation policy governance in Australia, Austria, Belgium (Flanders), Finland, Greece, Ireland, Japan, Korea, Netherlands, New Zealand, Norway and Sweden. It provides fresh insight into how governments are striving to make innovation policy more coherent.
In order to foster innovation in their countries, governments first need to be able to measure it. But what means do they have at their disposal? The Oslo Manual provides them with the essential methodological guidelines.
While many countries have invested in the production of health technology assessment, evidence about its use in decision making is limited. This report analyses the barriers to, and facilitators of, evidence-based decision making in OECD health-care systems.